Translating neonatal microbiome science into commercial innovation: metabolism of human milk oligosaccharides as a basis for probiotic efficacy in breast-fed infants

References

• Kitzinger S. The fourth trimester? Midwife Health Visit Community Nurse. 1975;11:118–25.
   PubMedGoogle Scholar
• Gerstley JR. Some factors influencing the fecal flora of infants. Arch Pediatr Adolesc Med. 1932;43(3):555. doi:10.1001/archpedi.1932.01950030025003.
   Google Scholar
• Tissier MH. Recherches sur la flore intestinale normale et pathologique du nourisson [Doctoral dissertation]. 1900.
   Google Scholar
• Brown EW. Studies of infant feeding xvi. Am J Dis Child. 1922;23(3):243. doi:10.1001/archpedi.1922.01910390062005.
   Google Scholar
• Logan WR. The intestinal flora of infants and young children. J Pathol Bacteriol. 1913;18(1):527–551. doi:10.1002/path.1700180154.
   Google Scholar
• Upton MF. The anaerobic intestinal flora of normal breast-fed and artificially fed infants. Arch Pediatr Adolesc Med. 1929;37(6):1221. doi:10.1001/archpedi.1929.01930060098013.
   Google Scholar
• Tissier MH. Repartition des microbes dans l’intestin du nourrisson. Ann Inst Pasteur (Paris). 1905;19:109–123.
   Google Scholar
• Gyorgy P. A hitherto unrecognized biochemical difference between human milk and cow’s milk. Pediatrics. 1953;11(2):98–108. doi:10.1542/peds.11.2.98.
   PubMed Web of Science ®Google Scholar
• Barbero GJ, Runge G, Fischer D, Crawford MN, Torres FE, Gyorgy P. Investigations on the bacterial flora, pH, and sugar content in the intestinal tract of infants. J Pediatr. 1952;40(2):152–163. doi:10.1016/S0022-3476(52)80176-3.
   PubMed Web of Science ®Google Scholar
• Norton RC. The hydrogen ion concentration of the stools of new-born infants. Arch Pediatr Adolesc Med. 1926;32(2):183. doi:10.1001/archpedi.1926.04130080023002.
   Google Scholar
• Tisdall FF. Studies on the acidity (hydrogen ion concentration) of infants’ stools. Arch Pediatr Adolesc Med. 1924;27(4):312. doi:10.1001/archpedi.1924.01920100017003.
   Google Scholar
• Marriott WM. The acidity of the gastric contents of infants. Arch Pediatr Adolesc Med. 1923;26(6):542. doi:10.1001/archpedi.1923.04120180041004.
   Google Scholar
• Kunz C. Historical aspects of human milk oligosaccharides. Adv Nutr. 2012;3(3):430S–439S. doi:10.3945/an.111.001776.
   PubMed Web of Science ®Google Scholar
• Gyorgy P, Norris RF, Rose CS. Bifidus factor. I. A variant of Lactobacillus bifidus requiring a special growth factor. Arch Biochem Biophys. 1954;48(1):193–201. doi:10.1016/0003-9861(54)90323-9.
   PubMed Web of Science ®Google Scholar
• Gyorgy P, Jr H, Kuhn R, Cs R, Bifidus factor. The rate of dialysis. Arch Biochem Biophys. 1954;48(1):209–213. doi:10.1016/0003-9861(54)90325-2. III.
   PubMed Web of Science ®Google Scholar
• Kunz C, Rudloff S, Baier W, Klein N, Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr. 2000;20(1):699–722. doi:10.1146/annurev.nutr.20.1.699.
   PubMed Web of Science ®Google Scholar
• Katayama T, Sakuma A, Kimura T, Makimura Y, Hiratake J, Sakata K, Yamanoi T, Kumagai H, Yamamoto K. Molecular cloning and characterization of Bifidobacterium bifidum 1,2-α-l -fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95). J Bacteriol. 2004;186(15):4885–4893. doi:10.1128/JB.186.15.4885-4893.2004.
   PubMed Web of Science ®Google Scholar
• Kitaoka M, Tian J, Nishimoto M. Novel putative galactose operon involving lacto-N-biose phosphorylase in Bifidobacterium longum. Appl Environ Microbiol. 2005;71(6):3158–3162. doi:10.1128/AEM.71.6.3158-3162.2005.
   PubMed Web of Science ®Google Scholar
• Ward RE, Niñonuevo M, Mills DA, Lebrilla CB, German JB. In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol Nutr Food Res. 2007;51(11):1398–1405. doi:10.1002/mnfr.200700150.
   PubMed Web of Science ®Google Scholar
• Ward RE, Niñonuevo M, Mills DA, Lebrilla CB, German JB. In vitro fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri. Appl Environ Microbiol. 2006;72(6):4497–4499. doi:10.1128/AEM.02515-05.
   PubMed Web of Science ®Google Scholar
• LoCascio RG, Ninonuevo MR, Freeman SL, Sela DA, Grimm R, Lebrilla CB, Mills DA, German JB. Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. J Agric Food Chem. 2007;55(22):8914–8919. doi:10.1021/jf0710480.
   PubMed Web of Science ®Google Scholar
• Locascio RG, Niñonuevo MR, Kronewitter SR, Freeman SL, German JB, Lebrilla CB, Mills DA. A versatile and scalable strategy for glycoprofiling bifidobacterial consumption of human milk oligosaccharides. Microb Biotechnol. 2009;2(3):333–342. doi:10.1111/j.1751-7915.2008.00072.x.
   PubMed Web of Science ®Google Scholar
• Ruhaak LR, Lebrilla CB. Analysis and role of oligosaccharides in milk. BMB Rep. 2012;45(8):442–451. doi:10.5483/BMBRep.2012.45.8.161.
   PubMed Web of Science ®Google Scholar
• Wu LD, Ruhaak LR, Lebrilla CB. Analysis of milk oligosaccharides by mass spectrometry. Methods Mol Biol. 2017;1503:121–129.
   PubMedGoogle Scholar
• Park Y, Lebrilla CB. Application of Fourier transform ion cyclotron resonance mass spectrometry to oligosaccharides. Mass Spectrom Rev. 2005;24(2):232–264. doi:10.1002/mas.20010.
   PubMed Web of Science ®Google Scholar
• Finke B, Mank M, Daniel H, Stahl B. Offline coupling of low-pressure anion-exchange chromatography with MALDI-MS to determine the elution order of human milk oligosaccharides. Anal Biochem. 2000;284(2):256–265. doi:10.1006/abio.2000.4680.
   PubMed Web of Science ®Google Scholar
• Wu S, Grimm R, German JB, Lebrilla CB. Annotation and structural analysis of sialylated human milk oligosaccharides. J Proteome Res. 2011;10(2):856–868. doi:10.1021/pr101006u.
   PubMed Web of Science ®Google Scholar
• Wu S, Tao N, German JB, Grimm R, Lebrilla CB. Development of an annotated library of neutral human milk oligosaccharides. J Proteome Res. 2010;9(8):4138–4151. doi:10.1021/pr100362f.
   PubMed Web of Science ®Google Scholar
• Totten SM, Wu LD, Parker EA, Davis JCC, Hua S, Stroble C, Ruhaak LR, Smilowitz JT, German JB, Lebrilla CB. Rapid-throughput glycomics applied to human milk oligosaccharide profiling for large human studies. Anal Bioanal Chem. 2014;406(30):7925–7935. doi:10.1007/s00216-014-8261-2.
   PubMed Web of Science ®Google Scholar
• Vinjamuri A, Davis JCC, Totten SM, Wu LD, Klein LD, Martin M, Quinn EA, Scelza B, Breakey A, Gurven M, et al. Human milk oligosaccharide compositions illustrate global variations in early nutrition. J Nutr. 2022;152(5):1239–1253. doi:10.1093/jn/nxac027.
   PubMed Web of Science ®Google Scholar
• Niñonuevo MR, Perkins PD, Francis J, Lamotte LM, LoCascio RG, Freeman SL, Mills DA, German JB, Grimm R, Lebrilla CB. Daily variations in oligosaccharides of human milk determined by microfluidic chips and mass spectrometry. J Agric Food Chem. 2008;56(2):618–626. doi:10.1021/jf071972u.
   PubMed Web of Science ®Google Scholar
• De Leoz MLA, Wu S, Strum JS, Niñonuevo MR, Gaerlan SC, Mirmiran M, German JB, Mills DA, Lebrilla CB, Underwood MA. A quantitative and comprehensive method to analyze human milk oligosaccharide structures in the urine and feces of infants. Anal Bioanal Chem. 2013;405(12):4089–4105. doi:10.1007/s00216-013-6817-1.
   PubMed Web of Science ®Google Scholar
• Ruhaak LR, Stroble C, Underwood MA, Lebrilla CB. Detection of milk oligosaccharides in plasma of infants. Anal Bioanal Chem. 2014;406(24):5775–5784. doi:10.1007/s00216-014-8025-z.
   PubMed Web of Science ®Google Scholar
• De Leoz MLA, Kalanetra KM, Bokulich NA, Strum JS, Underwood MA, German JB, Mills DA, Lebrilla CB. Human milk glycomics and gut microbial genomics in infant feces show a correlation between human milk oligosaccharides and gut microbiota: a proof-of-concept study. J Proteome Res. 2015;14(1):491–502. doi:10.1021/pr500759e.
   PubMed Web of Science ®Google Scholar
• LoCascio RG, Desai P, Sela DA, Weimer B, Mills DA. Broad conservation of milk utilization genes in Bifidobacterium longum subsp. infantis as revealed by comparative genomic hybridization. Appl Environ Microbiol. 2010;76(22):7373–7381. doi:10.1128/AEM.00675-10.
   PubMed Web of Science ®Google Scholar
• Kitaoka M. Bifidobacterial enzymes involved in the metabolism of human milk oligosaccharides. Adv Nutr. 2012;3(3):422S–429S. doi:10.3945/an.111.001420.
   PubMed Web of Science ®Google Scholar
• Garrido D, Ruiz-Moyano S, Kirmiz N, Davis JC, Totten SM, Lemay DG, Ugalde JA, German JB, Lebrilla CB, Mills DA. A novel gene cluster allows preferential utilization of fucosylated milk oligosaccharides in Bifidobacterium longum subsp. longum SC596. Sci Rep. 2016;6(1):35045. doi:10.1038/srep35045.
   PubMed Web of Science ®Google Scholar
• Ruiz-Moyano S, Totten SM, Garrido DA, Smilowitz JT, German JB, Lebrilla CB, Mills DA. Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve. Appl Environ Microbiol. 2013;79(19):6040–6049. doi:10.1128/AEM.01843-13.
   PubMed Web of Science ®Google Scholar
• Shani G, Hoeflinger JL, Heiss BE, Masarweh CF, Larke JA, Jensen NM, Wickramasinghe S, Davis JC, Goonatilleke E, El-Hawiet A, et al. Fucosylated human milk oligosaccharide foraging within the species Bifidobacterium pseudocatenulatum is driven by glycosyl hydrolase content and specificity. Appl Environ Microbiol. 2021;88(2):AEM0170721. doi:10.1128/AEM.01707-21.
   Web of Science ®Google Scholar
• Lawson MAE, O’neill IJ, Kujawska M, Gowrinadh Javvadi S, Wijeyesekera A, Flegg Z, Chalklen L, Hall LJ. Breast milk-derived human milk oligosaccharides promote Bifidobacterium interactions within a single ecosystem. ISME J. 2020;14(2):635–648. doi:10.1038/s41396-019-0553-2.
   PubMed Web of Science ®Google Scholar
• Bunesova V, Lacroix C, Schwab C. Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense. BMC Microbiol. 2016;16(1):248. doi:10.1186/s12866-016-0867-4.
   PubMedGoogle Scholar
• Strum JS, Kim J, Wu S, De Leoz MLA, Peacock K, Grimm R, German JB, Mills DA, Lebrilla CB. Identification and accurate quantitation of biological oligosaccharide mixtures. Anal Chem. 2012;84(18):7793–7801. doi:10.1021/ac301128s.
   PubMed Web of Science ®Google Scholar
• Matsuki T, Yahagi K, Mori H, Matsumoto H, Hara T, Tajima S, Ogawa E, Kodama H, Yamamoto K, Yamada T, et al. A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat Commun. 2016;7(1):11939. doi:10.1038/ncomms11939.
   PubMed Web of Science ®Google Scholar
• Turroni F, Milani C, Duranti S, Mahony J, van Sinderen D, Ventura M. Glycan utilization and cross-feeding activities by bifidobacteria. Trends Microbiol. 2018;26(4):339–350. doi:10.1016/j.tim.2017.10.001.
   PubMed Web of Science ®Google Scholar
• Marcobal A, Sonnenburg JL. Human milk oligosaccharide consumption by intestinal microbiota. Clin Microbiol Infect. 2012;18(Suppl 4):12–15. doi:10.1111/j.1469-0691.2012.03863.x.
   PubMed Web of Science ®Google Scholar
• Pichler MJ, Yamada C, Shuoker B, Alvarez-Silva C, Gotoh A, Leth ML, Schoof E, Katoh T, Sakanaka M, Katayama T, et al. Butyrate producing colonic Clostridiales metabolise human milk oligosaccharides and cross feed on mucin via conserved pathways. Nat Commun. 2020;11(1):3285. doi:10.1038/s41467-020-17075-x.
   PubMed Web of Science ®Google Scholar
• Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, Gopinath S, Naidu N, Choudhury B, Weimer BC, Monack DM, et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature. 2013;502(7469):96–99. doi:10.1038/nature12503.
   PubMed Web of Science ®Google Scholar
• Engevik MA, Engevik AC, Engevik KA, Auchtung JM, Chang-Graham AL, Ruan W, Luna RA, Hyser JM, Spinler JK, Versalovic J. Mucin-degrading microbes release monosaccharides that chemoattract clostridioides difficile and facilitate colonization of the human intestinal mucus layer. ACS Infect Dis. 2021;7(5):1126–1142. doi:10.1021/acsinfecdis.0c00634.
   PubMed Web of Science ®Google Scholar
• Huang Y-L, Chassard C, Hausmann M, von Itzstein M, Hennet T. Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice. Nat Commun. 2015;6(1):8141. doi:10.1038/ncomms9141.
   PubMedGoogle Scholar
• Sela DA, Chapman J, Adeuya A, Kim JH, Chen F, Whitehead TR, Lapidus A, Rokhsar DS, Lebrilla CB, German JB, et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci U S A. 2008;105(48):18964–18969. doi:10.1073/pnas.0809584105.
   PubMed Web of Science ®Google Scholar
• Sela DA, Garrido D, Lerno L, Wu S, Tan K, Eom H-J, Joachimiak A, Lebrilla CB, Mills DA. Bifidobacterium longum subsp. infantis ATCC 15697 α-fucosidases are active on fucosylated human milk oligosaccharides. Appl Environ Microbiol. 2012;78(3):795–803. doi:10.1128/AEM.06762-11.
   PubMed Web of Science ®Google Scholar
• Sela DA, Li Y, Lerno L, Wu S, Marcobal AM, German JB, Chen X, Lebrilla CB, Mills DA. An infant-associated bacterial commensal utilizes breast milk sialyloligosaccharides. J Biol Chem. 2011;286(14):11909–11918. doi:10.1074/jbc.M110.193359.
   PubMed Web of Science ®Google Scholar
• Garrido D, Ruiz-Moyano S, Jimenez-Espinoza R, Eom H-J, Block DE, Mills DA. Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolates. Food Microbiol. 2013;33(2):262–270. doi:10.1016/j.fm.2012.10.003.
   PubMed Web of Science ®Google Scholar
• Garrido D, Ruiz-Moyano S, Mills DA. Release and utilization of N-acetyl-D-glucosamine from human milk oligosaccharides by Bifidobacterium longum subsp. infantis. Anaerobe. 2012;18(4):430–435. doi:10.1016/j.anaerobe.2012.04.012.
   PubMed Web of Science ®Google Scholar
• Garrido D, Kim JH, German JB, Raybould HE, Mills DA . Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans. PLoS ONE. 2011;6(3):e17315. doi:10.1371/journal.pone.0017315.
   PubMed Web of Science ®Google Scholar
• Kim J-H, An HJ, Garrido D, German JB, Lebrilla CB, Mills DA, de Crécy-Lagard V, de Crécy-Lagard V. Proteomic analysis of Bifidobacterium longum subsp. infantis reveals the metabolic insight on consumption of prebiotics and host glycans. PLoS ONE. 2013;8(2):e57535. doi:10.1371/journal.pone.0057535.
   PubMed Web of Science ®Google Scholar
• Tarracchini C, Milani C, Lugli GA, Mancabelli L, Fontana F, Alessandri G, Longhi G, Anzalone R, Viappiani A, Turroni F, et al. Phylogenomic disentangling of the Bifidobacterium longum subsp. infantis taxon. Microb Genom. 2021;7(7). doi:10.1099/mgen.0.000609.
   PubMed Web of Science ®Google Scholar
• Albert K, Rani A, Sela DA. Comparative pangenomics of the mammalian gut commensal Bifidobacterium longum. Microorganisms. 2019;8(1):7. doi:10.3390/microorganisms8010007.
   PubMed Web of Science ®Google Scholar
• Zeng S, Patangia D, Almeida A, Zhou Z, Mu D, Paul Ross R, Stanton C, Wang S. A compendium of 32,277 metagenome-assembled genomes and over 80 million genes from the early-life human gut microbiome. Nat Commun. 2022;13(1):5139. doi:10.1038/s41467-022-32805-z.
   PubMed Web of Science ®Google Scholar
• Sonnenburg ED, Sonnenburg JL. The ancestral and industrialized gut microbiota and implications for human health. Nat Rev Microbiol. 2019;17(6):383–390. doi:10.1038/s41579-019-0191-8.
   PubMed Web of Science ®Google Scholar
• Reuter G. Designation of type strains for bifidobacterium species. Int J Syst Bacteriol. 1971;21(4):273–275. doi:10.1099/00207713-21-4-273.
   Google Scholar
• Mattarelli P, Bonaparte C, Pot B, Biavati B. Proposal to reclassify the three biotypes of Bifidobacterium longum as three subspecies: Bifidobacterium longum subsp. longum subsp. nov., Bifidobacterium longum subsp. infantis comb. nov. and Bifidobacterium longum subsp. suis comb. nov. Int J Syst Evol Microbiol. 2008;58(4):767–772. doi:10.1099/ijs.0.65319-0.
   PubMedGoogle Scholar
• Sakanaka M, Gotoh A, Yoshida K, Odamaki T, Koguchi H, Xiao J-Z, Kitaoka M, Katayama T. Varied pathways of infant gut-associated bifidobacterium to assimilate human milk oligosaccharides: prevalence of the gene set and its correlation with bifidobacteria-rich microbiota formation. Nutrients. 2019;12(1):71. doi:10.3390/nu12010071.
   PubMed Web of Science ®Google Scholar
• Tannock GW. New perceptions of the gut microbiota: implications for future research. Gastroenterol Clin North Am. 2005;3434(3):361–382. doi:10.1016/j.gtc.2005.05.006.
   PubMed Web of Science ®Google Scholar
• Bäckhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, Li Y, Xia Y, Xie H, Zhong H, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17(5):690–703. doi:10.1016/j.chom.2015.04.004.
   PubMed Web of Science ®Google Scholar
• Tannock GW, Ercolini D, Ercolini D. Building robust assemblages of bacteria in the human gut in early life. Appl Environ Microbiol. 2021;87(22):e0144921. doi:10.1128/AEM.01449-21.
   PubMed Web of Science ®Google Scholar
• Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO, Ruan Y, Ruan Y. Development of the human infant intestinal microbiota. PLoS Biol. 2007;5(7):e177. doi:10.1371/journal.pbio.0050177.
   PubMed Web of Science ®Google Scholar
• Barratt MJ, Ahmed T, Gordon JI. Gut microbiome development and childhood undernutrition. Cell Host Microbe. 2022;30(5):617–626. doi:10.1016/j.chom.2022.04.002.
   PubMed Web of Science ®Google Scholar
• Huda MN, Ahmad SM, Alam MJ, Khanam A, Kalanetra KM, Taft DH, Raqib R, Underwood MA, Mills DA, Stephensen CB. Bifidobacterium abundance in early infancy and vaccine response at 2 years of age. Pediatrics. 2019;143(2). doi:10.1542/peds.2018-1489.
   PubMed Web of Science ®Google Scholar
• Taft DH, Lewis ZT, Nguyen N, Ho S, Masarweh C, Dunne-Castagna V, Tancredi DJ, Huda MN, Stephensen CB, Hinde K, et al. Bifidobacterium species colonization in infancy: a global cross-sectional comparison by population history of breastfeeding. Nutrients. 2022;14(7):1423. doi:10.3390/nu14071423.
   PubMed Web of Science ®Google Scholar
• Tannock GW, Lee PS, Wong KH, Lawley B. Why don’t all infants have bifidobacteria in their stool? Front Microbiol. 2016;7:834. doi:10.3389/fmicb.2016.00834.
   PubMed Web of Science ®Google Scholar
• Vatanen T, Plichta DR, Somani J, Münch PC, Arthur TD, Hall AB, Rudolf S, Oakeley EJ, Ke X, Young RA, et al. Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life. Nat Microbiol. 2019;4(3):470–479. doi:10.1038/s41564-018-0321-5.
   PubMed Web of Science ®Google Scholar
• Taft DH, Liu J, Maldonado-Gomez MX, Akre S, Huda MN, Ahmad SM, Stephensen CB, Mills DA, Suen G, Suen G. Bifidobacterial dominance of the gut in early life and acquisition of antimicrobial resistance. mSphere. 2018;3(5). doi:10.1128/mSphere.00441-18.
   PubMed Web of Science ®Google Scholar
• Seppo AE, Bu K, Jumabaeva M, Thakar J, Choudhury RA, Yonemitsu C, Bode L, Martina CA, Allen M, Tamburini S, et al. Infant gut microbiome is enriched with Bifidobacterium longum ssp. infantis in old order Mennonites with traditional farming lifestyle. Allergy. 2021;76(11):3489–3503. doi:10.1111/all.14877.
   PubMed Web of Science ®Google Scholar
• Xu J, Lawley B, Wong G, Otal A, Chen L, Ying TJ, Lin X, Pang WW, Yap F, Chong Y-S, et al. Ethnic diversity in infant gut microbiota is apparent before the introduction of complementary diets. Gut Microbes. 2020;11(5):1362–1373. doi:10.1080/19490976.2020.1756150.
   PubMed Web of Science ®Google Scholar
• Jordan A, Carding SR, Hall LJ. The early-life gut microbiome and vaccine efficacy. Lancet Microbe. 2022;3(10):e787–94. doi:10.1016/S2666-5247(22)00185-9.
   PubMedGoogle Scholar
• Young SL, Simon MA, Baird MA, Tannock GW, Bibiloni R, Spencely K, Lane JM, Fitzharris P, Crane J, Town I, et al. Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diagn Lab Immunol. 2004;11(4):686–690. doi:10.1128/CDLI.11.4.686-690.2004.
   PubMedGoogle Scholar
• Vatanen T, Kostic AD, d’Hennezel E, Siljander H, Franzosa EA, Yassour M, Kolde R, Vlamakis H, Arthur TD, Hämäläinen A-M, et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell. 2016;165(4):842–853. doi:10.1016/j.cell.2016.04.007.
   PubMed Web of Science ®Google Scholar
• Davis JCC, Lewis ZT, Krishnan S, Bernstein RM, Moore SE, Prentice AM, Mills DA, Lebrilla CB, Zivkovic AM. Growth and morbidity of Gambian infants are influenced by maternal milk oligosaccharides and infant gut microbiota. Sci Rep. 2017;7(1):40466. doi:10.1038/srep40466.
   PubMedGoogle Scholar
• Lawley B, Otal A, Moloney-Geany K, Diana A, Houghton L, Heath AL, Taylor RW, Tannock GW, Elkins CA. Fecal Microbiotas of Indonesian and New Zealand children differ in complexity and bifidobacterial taxa during the first year of life. Appl Environ Microbiol. 2019;85(19). doi:10.1128/AEM.01105-19.
   PubMed Web of Science ®Google Scholar
• Casaburi G, Duar RM, Brown H, Mitchell RD, Kazi S, Chew S, Cagney O, Flannery RL, Sylvester KG, Frese SA, et al. Metagenomic insights of the infant microbiome community structure and function across multiple sites in the United States. Sci Rep. 2021;11(1):1472. doi:10.1038/s41598-020-80583-9.
   PubMed Web of Science ®Google Scholar
• Lewis ZT, Totten SM, Smilowitz JT, Popovic M, Parker E, Lemay DG, Van Tassell ML, Miller MJ, Jin Y-S, German JB, et al. Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants. Microbiome. 2015;3(1):13. doi:10.1186/s40168-015-0071-z.
   PubMedGoogle Scholar
• Huda MN, Lewis Z, Kalanetra KM, Rashid M, Ahmad SM, Raqib R, Qadri F, Underwood MA, Mills DA, Stephensen CB. Stool microbiota and vaccine responses of infants. Pediatrics. 2014;134(2):e362–72. doi:10.1542/peds.2013-3937.
   PubMed Web of Science ®Google Scholar
• Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–227. doi:10.1038/nature11053.
   PubMed Web of Science ®Google Scholar
• Olm MR, Dahan D, Carter MM, Merrill BD, Yu FB, Jain S, Meng X, Tripathi S, Wastyk H, Neff N, et al. Robust variation in infant gut microbiome assembly across a spectrum of lifestyles. Science. 2022;376(6598):1220–1223. doi:10.1126/science.abj2972.
   PubMed Web of Science ®Google Scholar
• Underwood MA, German JB, Lebrilla CB, Mills DA. Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut. Pediatr Res. 2015;77(1–2):229–235. doi:10.1038/pr.2014.156.
   PubMed Web of Science ®Google Scholar
• Bello MGD, Knight R, Gilbert JA, Blaser MJ. Preserving microbial diversity. Science. 2018;362(6410):33–34. doi:10.1126/science.aau8816.
   PubMed Web of Science ®Google Scholar
• Sonnenburg JL, Sonnenburg ED. Vulnerability of the industrialized microbiota. Science. 2019;366(6464). doi:10.1126/science.aaw9255.
   Web of Science ®Google Scholar
• Bokulich NA, Chung J, Battaglia T, Henderson N, Jay M, Li H, Lieber DA, Wu F, Gi PP, Chen Y, et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med. 2016;8(343):343ra82. doi:10.1126/scitranslmed.aad7121.
   PubMed Web of Science ®Google Scholar
• Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107(26):11971–11975. doi:10.1073/pnas.1002601107.
   PubMed Web of Science ®Google Scholar
• Davis EC, Castagna VP, Sela DA, Hillard MA, Lindberg S, Mantis NJ, Seppo AE, Järvinen KM. Gut microbiome and breast-feeding: implications for early immune development. J Allergy Clin Immunol. 2022;150(3):523–534. doi:10.1016/j.jaci.2022.07.014.
   PubMed Web of Science ®Google Scholar
• Healy DB, Ryan CA, Ross RP, Stanton C, Dempsey EM. Clinical implications of preterm infant gut microbiome development. Nat Microbiol. 2022;7(1):22–33. doi:10.1038/s41564-021-01025-4.
   PubMed Web of Science ®Google Scholar
• Zwittink RD, Renes IB, van Lingen RA, van Zoeren-Grobben D, Konstanti P, Norbruis OF, Martin R, Groot Jebbink LJM, Knol J, Belzer C. Association between duration of intravenous antibiotic administration and early-life microbiota development in late-preterm infants. Eur J Clin Microbiol Infect Dis. 2018;37(3):475–483. doi:10.1007/s10096-018-3193-y.
   PubMed Web of Science ®Google Scholar
• Henderickx JGE, Zwittink RD, van Lingen RA, Knol J, Belzer C. The preterm gut microbiota: an inconspicuous challenge in nutritional neonatal care. Front Cell Infect Microbiol. 2019;9:85. doi:10.3389/fcimb.2019.00085.
   PubMed Web of Science ®Google Scholar
• Goldmann DA. The bacterial flora of neonates in intensive care-monitoring and manipulation. J Hosp Infect. 1988;11(Suppl A):340–351. doi:10.1016/0195-6701(88)90209-5.
   PubMedGoogle Scholar
• Casaburi G, Wei J, Kazi S, Liu J, Wang K, Tao G-Z, Lin P-Y, Dunn JCY, Henrick BM, Frese SA, et al. Metabolic model of necrotizing enterocolitis in the premature newborn gut resulting from enteric dysbiosis. Front Pediatr. 2022;10:893059. doi:10.3389/fped.2022.893059.
   PubMed Web of Science ®Google Scholar
• Lawrence G, Bates J, Gaul A. Pathogenesis of neonatal necrotising enterocolitis. Lancet. 1982;1(8264):137–139. doi:10.1016/S0140-6736(82)90383-X.
   PubMed Web of Science ®Google Scholar
• Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet. 2007;369(9573):1614–1620. doi:10.1016/S0140-6736(07)60748-X.
   PubMed Web of Science ®Google Scholar
• Morgan RL, Preidis GA, Kashyap PC, Weizman AV, Sadeghirad B, Chang Y, Florez ID, Foroutan F, Shahid S, Zeraatkar D, et al. Probiotics reduce mortality and morbidity in preterm, low-birth-weight infants: a systematic review and network meta-analysis of randomized trials. Gastroenterology. 2020;159(2):467–480. doi:10.1053/j.gastro.2020.05.096.
   PubMed Web of Science ®Google Scholar
• Deshmukh M, Patole S. Prophylactic probiotic supplementation for preterm neonates—a systematic review and meta-analysis of nonrandomized studies. Adv Nutr. 2021;12(4):1411–1423. doi:10.1093/advances/nmaa164.
   PubMed Web of Science ®Google Scholar
• Sharif S, Meader N, Oddie SJ, Rojas-Reyes MX, McGuire W. Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants. Cochrane Database Syst Rev. 2020;10(10):CD005496. doi:10.1002/14651858.CD005496.pub5.
   PubMedGoogle Scholar
• Barbian ME, Patel RM. Probiotics for prevention of necrotizing enterocolitis: where do we stand? Semin Perinatol. 2022;47(1):151689. doi:10.1016/j.semperi.2022.151689.
   PubMed Web of Science ®Google Scholar
• Neu J. Routine probiotics for premature infants: let’s be careful! J Pediatr. 2011;158(4):672–674. doi:10.1016/j.jpeds.2010.11.028.
   PubMed Web of Science ®Google Scholar
• Poindexter B, Cummings J, Hand I, Adams-Chapman I, Aucott SW, Puopolo KM, Goldsmith JP, Kaufman D, Martin C, Mowitz M, et al. Use of probiotics in preterm infants. Pediatrics. 2021;147(6). doi:10.1542/peds.2021-051485.
   Web of Science ®Google Scholar
• WHO recommendations for care of the preterm or low-birth-weight infant. Geneva: World Health Organization; 2022. https://www.ncbi.nlm.nih.gov/books/NBK586704/.
   Google Scholar
• Duar RM, Henrick BM, Casaburi G, Frese SA. Integrating the ecosystem services framework to define dysbiosis of the breastfed infant gut: the role of B. infantis and human milk oligosaccharides. Front Nutr. 2020;7:33. doi:10.3389/fnut.2020.00033.
   PubMed Web of Science ®Google Scholar
• Seedorf H, Griffin NW, Ridaura VK, Reyes A, Cheng J, Rey FE, Smith MI, Simon GM, Scheffrahn RH, Woebken D, et al. Bacteria from diverse habitats colonize and compete in the mouse gut. Cell. 2014;159(2):253–266. doi:10.1016/j.cell.2014.09.008.
   PubMed Web of Science ®Google Scholar
• Taft DH, Ambalavanan N, Schibler KR, Yu Z, Newburg DS, Ward DV, Morrow AL. Intestinal microbiota of preterm infants differ over time and between hospitals. Microbiome. 2014;2(1):36. doi:10.1186/2049-2618-2-36.
   PubMedGoogle Scholar
• Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics. 2010;125(5):921–930. doi:10.1542/peds.2009-1301.
   PubMed Web of Science ®Google Scholar
• Bollrath J, Powrie F. Feed your Tregs more fiber. Science. 2013 Immunology;341(6145):463–464. doi:10.1126/science.1242674.
   PubMed Web of Science ®Google Scholar
• Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, de Los Reyes-Gavilán CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol. 2016;7:185. doi:10.3389/fmicb.2016.00185.
   PubMed Web of Science ®Google Scholar
• Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341(6145):569–573. doi:10.1126/science.1241165.
   PubMed Web of Science ®Google Scholar
• Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461(7268):1282–1286. doi:10.1038/nature08530.
   PubMed Web of Science ®Google Scholar
• Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469(7331):543–547. doi:10.1038/nature09646.
   PubMed Web of Science ®Google Scholar
• O’brien CE, Meier AK, Cernioglo K, Mitchell RD, Casaburi G, Frese SA, Henrick BM, Underwood MA, Smilowitz JT. Early probiotic supplementation with B. infantis in breastfed infants leads to persistent colonization at 1 year. Pediatr Res. 2022;91(3):627–636. doi:10.1038/s41390-020-01350-0.
   PubMed Web of Science ®Google Scholar
• Frese SA, Hutton AA, Contreras LN, Shaw CA, Palumbo MC, Casaburi G, Xu G, Davis JCC, Lebrilla CB, Henrick BM, et al. Persistence of supplemented Bifidobacterium longum subsp. infantis EVC001 in breastfed infants. mSphere. 2017;2(6). doi:10.1128/mSphere.00501-17.
   PubMed Web of Science ®Google Scholar
• Larke JA, Kuhn-Riordon K, Taft DH, Sohn K, Iqbal S, Underwood MA, Mills DA, Slupsky CM. Preterm infant fecal microbiota and metabolite profiles are modulated in a probiotic specific manner. J Pediatr Gastroenterol Nutr. 2022;75(4):535–542. doi:10.1097/MPG.0000000000003570.
   PubMed Web of Science ®Google Scholar
• Alcon-Giner C, Dalby MJ, Caim S, Ketskemety J, Shaw A, Sim K, Lawson MAE, Kiu R, Leclaire C, Chalklen L, et al. Microbiota supplementation with Bifidobacterium and Lactobacillus modifies the preterm infant gut microbiota and metabolome: an observational study. Cell Rep Med. 2020;1(5):100077. doi:10.1016/j.xcrm.2020.100077.
   PubMedGoogle Scholar
• Marcobal A, Barboza M, Froehlich JW, Block DE, German JB, Lebrilla CB, Mills DA. Consumption of human milk oligosaccharides by gut-related microbes. J Agric Food Chem. 2010;58(9):5334–5340. doi:10.1021/jf9044205.
   PubMed Web of Science ®Google Scholar
• Turroni F, Bottacini F, Foroni E, Mulder I, Kim J-H, Zomer A, Sánchez B, Bidossi A, Ferrarini A, Giubellini V, et al. Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl Acad Sci U S A. 2010;107(45):19514–19519. doi:10.1073/pnas.1011100107.
   PubMed Web of Science ®Google Scholar
• Watkins C, Murphy K, Dempsey EM, O’shea CA, Murphy BP, O’toole PW, Ross RP, Stanton C, Ryan CA. Dose-interval study of a dual probiotic in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2019;104(2):F159–64. doi:10.1136/archdischild-2017-313468.
   PubMed Web of Science ®Google Scholar
• Samara J, Moossavi S, Alshaikh B, Ortega VA, Pettersen VK, Ferdous T, Hoops SL, Soraisham A, Vayalumkal J, Dersch-Mills D, et al. Supplementation with a probiotic mixture accelerates gut microbiome maturation and reduces intestinal inflammation in extremely preterm infants. Cell Host Microbe. 2022;30(5):696–711.e5. doi:10.1016/j.chom.2022.04.005.
   PubMed Web of Science ®Google Scholar
• Beck LC, Masi AC, Young GR, Vatanen T, Lamb CA, Smith R, Coxhead J, Butler A, Marsland BJ, Embleton ND, et al. Strain-specific impacts of probiotics are a significant driver of gut microbiome development in very preterm infants. Nat Microbiol. 2022;7(10):1525–1535. doi:10.1038/s41564-022-01213-w.
   PubMed Web of Science ®Google Scholar
• Larsen IS, Jensen BAH, Bonazzi E, Choi BSY, Kristensen NN, Schmidt EGW, Süenderhauf A, Morin L, Olsen PB, Hansen LBS, et al. Fungal lysozyme leverages the gut microbiota to curb DSS-induced colitis. Gut Microbes. 2021;13(1):1988836. doi:10.1080/19490976.2021.1988836.
   PubMed Web of Science ®Google Scholar
• Dunne-Castagna VP, Mills DA, Lönnerdal B. Effects of milk secretory immunoglobulin a on the commensal microbiota. Nestle Nutr Inst Workshop Ser. 2020;94:158–168.
   PubMedGoogle Scholar
• Lönnerdal B, Iyer S. Lactoferrin: molecular structure and biological function. Annu Rev Nutr. 1995;15(1):93–110. doi:10.1146/annurev.nu.15.070195.000521.
   PubMedGoogle Scholar
• Liepke C, Zucht H-D, Forssmann W-G, Ständker L. Purification of novel peptide antibiotics from human milk. J Chromatogr B Biomed Sci Appl. 2001;752(2):369–377. doi:10.1016/S0378-4347(00)00516-8.
   PubMed Web of Science ®Google Scholar
• Jones EM, Smart A, Bloomberg G, Burgess L, Millar MR. Lactoferricin, a new antimicrobial peptide. J Appl Bacteriol. 1994;77(2):208–214. doi:10.1111/j.1365-2672.1994.tb03065.x.
   PubMedGoogle Scholar
• Dallas DC, Guerrero A, Khaldi N, Castillo PA, Martin WF, Smilowitz JT, Bevins CL, Barile D, German JB, Lebrilla CB. Extensive in vivo human milk peptidomics reveals specific proteolysis yielding protective antimicrobial peptides. J Proteome Res. 2013;12(5):2295–2304. doi:10.1021/pr400212z.
   PubMed Web of Science ®Google Scholar
• Schlievert PM, Kilgore SH, Seo KS, Leung DYM. Glycerol monolaurate contributes to the antimicrobial and anti-inflammatory activity of human milk. Sci Rep. 2019;9(1):14550. doi:10.1038/s41598-019-51130-y.
   PubMedGoogle Scholar
• Shin K, Tomita M, Lönnerdal B. Identification of lactoperoxidase in mature human milk. J Nutr Biochem. 2000;11(2):94–102. doi:10.1016/S0955-2863(99)00082-0.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS. Campylobacter jejuni binds intestinal H(O) antigen (Fucα1, 2Galβ1, 4glcnac), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem. 2003;278(16):14112–14120. doi:10.1074/jbc.M207744200.
   PubMed Web of Science ®Google Scholar
• Liepke C, Adermann K, Raida M, Mägert H-J, Forssmann W-G, Zucht H-D. Human milk provides peptides highly stimulating the growth of bifidobacteria. Eur J Biochem. 2002;269(2):712–718. doi:10.1046/j.0014-2956.2001.02712.x.
   PubMedGoogle Scholar
• Oda H, Wakabayashi H, Yamauchi K, Sato T, Xiao J-Z, Abe F, Iwatsuki K. Isolation of a bifidogenic peptide from the pepsin hydrolysate of bovine lactoferrin. Appl Environ Microbiol. 2013;79(6):1843–1849. doi:10.1128/AEM.03343-12.
   PubMed Web of Science ®Google Scholar
• Robinson RC. Structures and metabolic properties of bovine milk oligosaccharides and their potential in the development of novel therapeutics. Front Nutr. 2019;6:50. doi:10.3389/fnut.2019.00050.
   PubMed Web of Science ®Google Scholar
• Marsaux B, Van den Abbeele P, Ghyselinck J, Prioult G, Marzorati M, Bogićević B. Synbiotic Effect of Bifidobacterium lactis CNCM I-3446 and bovine milk-derived oligosaccharides on infant gut microbiota. Nutrients. 2020;12(8):2268. doi:10.3390/nu12082268.
   PubMed Web of Science ®Google Scholar
• Heiss BE, Ehrlich AM, Maldonado-Gomez MX, Taft DH, Larke JA, Goodson ML, Slupsky CM, Tancredi DJ, Raybould HE, Mills DA. Bifidobacterium catabolism of human milk oligosaccharides overrides endogenous competitive exclusion driving colonization and protection. Gut Microbes. 2021;13(1):1986666. doi:10.1080/19490976.2021.1986666.
   PubMed Web of Science ®Google Scholar
• Olsan EE, Byndloss MX, Faber F, Rivera-Chávez F, Tsolis RM, Bäumler AJ. Colonization resistance: the deconvolution of a complex trait. J Biol Chem. 2017;292(21):8577–8581. doi:10.1074/jbc.R116.752295.
   PubMed Web of Science ®Google Scholar
• Albright MBN, Louca S, Winkler DE, Feeser KL, Haig S-J, Whiteson KL, Emerson JB, Dunbar J. Solutions in microbiome engineering: prioritizing barriers to organism establishment. Isme J. 2022;16(2):331–338. doi:10.1038/s41396-021-01088-5.
   PubMed Web of Science ®Google Scholar
• Shepherd ES, DeLoache WC, Pruss KM, Whitaker WR, Sonnenburg JL. An exclusive metabolic niche enables strain engraftment in the gut microbiota. Nature. 2018;557(7705):434–438. doi:10.1038/s41586-018-0092-4.
   PubMed Web of Science ®Google Scholar
• Kearney SM, Gibbons SM, Erdman SE, Alm EJ. Orthogonal dietary niche enables reversible engraftment of a gut bacterial commensal. Cell Rep. 2018;24(7):1842–1851. doi:10.1016/j.celrep.2018.07.032.
   PubMed Web of Science ®Google Scholar
• Button JE, Autran CA, Reens AL, Cosetta CM, Smriga S, Ericson M, Pierce JV, Cook DN, Lee ML, Sun AK, et al. Dosing a synbiotic of human milk oligosaccharides and B. infantis leads to reversible engraftment in healthy adult microbiomes without antibiotics. Cell Host Microbe. 2022;30(5):712–725.e7. doi:10.1016/j.chom.2022.04.001.
   PubMed Web of Science ®Google Scholar
• Musilova S, Modrackova N, Hermanova P, Hudcovic T, Svejstil R, Rada V, Tejnecky V, Bunesova V. Assessment of the synbiotic properites of human milk oligosaccharides and Bifidobacterium longum subsp. infantis in vitro and in humanised mice. Benef Microbes. 2017;8(2):281–289. doi:10.3920/BM2016.0138.
   PubMed Web of Science ®Google Scholar
• Henrick BM, Hutton AA, Palumbo MC, Casaburi G, Mitchell RD, Underwood MA, Smilowitz JT, Frese SA, Oh J. Elevated fecal ph indicates a profound change in the breastfed infant gut microbiome due to reduction of bifidobacterium over the past century. mSphere. 2018;3(2). doi:10.1128/mSphere.00041-18.
   PubMed Web of Science ®Google Scholar
• Hossain MS, Das S, Gazi MA, Alam MA, Haque NMS, Mahfuz M, Ahmed T, Damman CJ. Association of faecal pH with childhood stunting: results from a cross-sectional study. BMJ Peds Open. 2019;3(1):e000549. doi:10.1136/bmjpo-2019-000549.
   PubMed Web of Science ®Google Scholar
• Washabaugh JR. First foods. Intestinal Ecology, and Early Life Health and Growth Outcomes [Doctoral dissertation].Boulder (CO): University of Colorado; 2021.
   Google Scholar
• Liu M, Nieuwdorp M, de Vos WM, Rampanelli E. Microbial tryptophan metabolism tunes host immunity, metabolism, and extraintestinal disorders. Metabolites. 2022;12(9):834. doi:10.3390/metabo12090834.
   PubMed Web of Science ®Google Scholar
• Aragozzini F, Ferrari A, Pacini N, Gualandris R. Indole-3-lactic acid as a tryptophan metabolite produced by Bifidobacterium spp. Appl Environ Microbiol. 1979;38(3):544–546. doi:10.1128/aem.38.3.544-546.1979.
   PubMed Web of Science ®Google Scholar
• Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23(6):716–724. doi:10.1016/j.chom.2018.05.003.
   PubMed Web of Science ®Google Scholar
• Meng D, Sommella E, Salviati E, Campiglia P, Ganguli K, Djebali K, Zhu W, Walker WA. Indole-3-lactic acid, a metabolite of tryptophan, secreted by Bifidobacterium longum subspecies infantis is anti-inflammatory in the immature intestine. Pediatr Res. 2020;88(2):209–217. doi:10.1038/s41390-019-0740-x.
   PubMed Web of Science ®Google Scholar
• Laursen MF, Sakanaka M, von Burg N, Mörbe U, Andersen D, Moll JM, Pekmez CT, Rivollier A, Michaelsen KF, Mølgaard C, et al. Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut. Nat Microbiol. 2021;6(11):1367–1382. doi:10.1038/s41564-021-00970-4.
   PubMed Web of Science ®Google Scholar
• Sakurai T, Odamaki T, Xiao J-Z. Production of indole-3-lactic acid by Bifidobacterium strains isolated from human infants. Microorganisms. 2019;7(9):340. doi:10.3390/microorganisms7090340.
   PubMed Web of Science ®Google Scholar
• Ehrlich AM, Pacheco AR, Henrick BM, Taft D, Xu G, Huda MN, Mishchuk D, Goodson ML, Slupsky C, Barile D, et al. Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells. BMC Microbiol. 2020;20(1):357. doi:10.1186/s12866-020-02023-y.
   PubMed Web of Science ®Google Scholar
• Henrick BM, Rodriguez L, Lakshmikanth T, Pou C, Henckel E, Arzoomand A, Olin A, Wang J, Mikes J, Tan Z, et al. Bifidobacteria-mediated immune system imprinting early in life. Cell. 2021;184(15):3884–3898.e11. doi:10.1016/j.cell.2021.05.030.
   PubMed Web of Science ®Google Scholar
• Arrieta M-C, Stiemsma LT, Dimitriu PA, Thorson L, Russell S, Yurist-Doutsch S, Kuzeljevic B, Gold MJ, Britton HM, Lefebvre DL, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015;7(307):307ra152. doi:10.1126/scitranslmed.aab2271.
   PubMed Web of Science ®Google Scholar
• Jena PK, Sheng L, Nagar N, Wu C, Barile D, Mills DA, Wan YJ. Synbiotics Bifidobacterium infantis and milk oligosaccharides are effective in reversing cancer-prone nonalcoholic steatohepatitis using western diet-fed FXR knockout mouse models. J Nutr Biochem. 2018;57:246–254. doi:10.1016/j.jnutbio.2018.04.007.
   PubMed Web of Science ®Google Scholar
• Henrick BM, Chew S, Casaburi G, Brown HK, Frese SA, Zhou Y, Underwood MA, Smilowitz JT. Colonization by B. infantis EVC001 modulates enteric inflammation in exclusively breastfed infants. Pediatr Res. 2019;86(6):749–757. doi:10.1038/s41390-019-0533-2.
   PubMed Web of Science ®Google Scholar
• Casaburi G, Duar RM, Vance DP, Mitchell R, Contreras L, Frese SA, Smilowitz JT, Underwood MA. Early-life gut microbiome modulation reduces the abundance of antibiotic-resistant bacteria. Antimicrob Resist Infect Control. 2019;8(1):131. doi:10.1186/s13756-019-0583-6.
   PubMed Web of Science ®Google Scholar
• Nguyen M, Holdbrooks H, Mishra P, Abrantes MA, Eskew S, Garma M, Oca C-G, McGuckin C, Hein CB, Mitchell RD, et al. Impact of probiotic B. infantis EVC001 feeding in premature infants on the gut microbiome, nosocomially acquired antibiotic resistance, and enteric inflammation. Front Pediatr. 2021;9:618009. doi:10.3389/fped.2021.618009.
   PubMed Web of Science ®Google Scholar
• Costeloe K, Hardy P, Juszczak E, Wilks M, Millar MR, Probiotics in Preterm Infants Study Collaborative Group. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet. 2016;387(10019):649–660. doi:10.1016/S0140-6736(15)01027-2.
   PubMed Web of Science ®Google Scholar
• Millar M, Seale J, Greenland M, Hardy P, Juszczak E, Wilks M, Panton N, Costeloe K, Wade WG. The microbiome of infants recruited to a randomised placebo-controlled probiotic trial (PiPS Trial). EBioMedicine. 2017;20:255–262. doi:10.1016/j.ebiom.2017.05.019.
   PubMed Web of Science ®Google Scholar
• Robertson C, Savva GM, Clapuci R, Jones J, Maimouni H, Brown E, Minocha A, Hall LJ, Clarke P. Incidence of necrotising enterocolitis before and after introducing routine prophylactic Lactobacillus and Bifidobacterium probiotics. Arch Dis Child Fetal Neonatal Ed. 2020;105(4):380–386. doi:10.1136/archdischild-2019-317346.
   PubMed Web of Science ®Google Scholar
• Denkel LA, Schwab F, Garten L, Geffers C, Gastmeier P, Piening B, Kollmann TR. Protective effect of dual-strain probiotics in preterm infants: a multi-center time series analysis. PLoS ONE. 2016;11(6):e0158136. doi:10.1371/journal.pone.0158136.
   PubMed Web of Science ®Google Scholar
• Guthmann F, Kluthe C, Bührer C. Probiotics for prevention of necrotising enterocolitis: an updated meta-analysis. Klinische Pädiatrie. 2010;222(05):284–290. doi:10.1055/s-0030-1254113.
   PubMedGoogle Scholar
• Lin H-C, Hsu C-H, Chen H-L, Chung M-Y, Hsu J-F, Lien R, Tsao L-Y, Chen C-H, B-H S. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics. 2008;122(4):693–700. doi:10.1542/peds.2007-3007.
   PubMed Web of Science ®Google Scholar
• Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis. 1999;3(4):197–202. doi:10.1016/S1201-9712(99)90024-3.
   PubMedGoogle Scholar
• Guthmann F, Arlettaz Mieth RP, Bucher HU, Bührer C. Short courses of dual-strain probiotics appear to be effective in reducing necrotising enterocolitis. Acta Paediatr. 2016;105(3):255–259. doi:10.1111/apa.13280.
   PubMed Web of Science ®Google Scholar
• Repa A, Thanhaeuser M, Endress D, Weber M, Kreissl A, Binder C, Berger A, Haiden N. Probiotics (Lactobacillus acidophilus and Bifidobacterium infantis) prevent NEC in VLBW infants fed breast milk but not formula [corrected]. Pediatr Res. 2015;77(2):381–388. doi:10.1038/pr.2014.192.
   PubMed Web of Science ®Google Scholar
• Härtel C, Pagel J, Rupp J, Bendiks M, Guthmann F, Rieger-Fackeldey E, Heckmann M, Franz A, Schiffmann J-H, Zimmermann B, et al. Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very low birth weight infants. J Pediatr. 2014;165(2):285–289.e1. doi:10.1016/j.jpeds.2014.04.029.
   PubMed Web of Science ®Google Scholar
• Lewis ZT, Shani G, Masarweh CF, Popovic M, Frese SA, Sela DA, Underwood MA, Mills DA. Validating bifidobacterial species and subspecies identity in commercial probiotic products. Pediatr Res. 2016;79(3):445–452. doi:10.1038/pr.2015.244.
   PubMed Web of Science ®Google Scholar
• Tobias J, Olyaei A, Laraway B, Jordan BK, Dickinson SL, Golzarri-Arroyo L, Fialkowski E, Owora A, Scottoline B. Bifidobacterium longum subsp. infantis EVC001 administration is associated with a significant reduction in the incidence of necrotizing enterocolitis in very low birth weight infants. J Pediatr. 2022;244:64–71.e2. doi:10.1016/j.jpeds.2021.12.070.
   PubMed Web of Science ®Google Scholar
• Lebeer S, Bron PA, Marco ML, Van Pijkeren J-P, O’connell Motherway M, Hill C, Pot B, Roos S, Klaenhammer T. Identification of probiotic effector molecules: present state and future perspectives. Curr Opin Biotechnol. 2018;49:217–223. doi:10.1016/j.copbio.2017.10.007.
   PubMed Web of Science ®Google Scholar
• Sanders ME, Benson A, Lebeer S, Merenstein DJ, Klaenhammer TR. Shared mechanisms among probiotic taxa: implications for general probiotic claims. Curr Opin Biotechnol. 2018;49:207–216. doi:10.1016/j.copbio.2017.09.007.
   PubMed Web of Science ®Google Scholar
• Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. 2019;25(5):716–729. doi:10.1038/s41591-019-0439-x.
   PubMed Web of Science ®Google Scholar
• Subramanian S, Huq S, Yatsunenko T, Haque R, Mahfuz M, Alam MA, Benezra A, DeStefano J, Meier MF, Muegge BD, et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature. 2014;510(7505):417–421. doi:10.1038/nature13421.
   PubMed Web of Science ®Google Scholar
• Ojima MN, Jiang L, Arzamasov AA, Yoshida K, Odamaki T, Xiao J, Nakajima A, Kitaoka M, Hirose J, Urashima T, et al. Priority effects shape the structure of infant-type Bifidobacterium communities on human milk oligosaccharides. Isme J. 2022;16:2265–2279. doi:10.1038/s41396-022-01270-3.
   PubMed Web of Science ®Google Scholar
• Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EMM, Sanders ME, Shamir R, Swann JR, Szajewska H, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18(9):649–667. doi:10.1038/s41575-021-00440-6.
   PubMed Web of Science ®Google Scholar
• Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al. Expert consensus document. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514. doi:10.1038/nrgastro.2014.66.
   PubMed Web of Science ®Google Scholar
• Swanson KS, Gibson GR, Hutkins R, Reimer RA, Reid G, Verbeke K, Scott KP, Holscher HD, Azad MB, Delzenne NM, et al. The international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 2020;17(11):687–701. doi:10.1038/s41575-020-0344-2.
   PubMed Web of Science ®Google Scholar
• Orla-Jensen. La classification des bactéries lactiques. Le Lait. 1924;4(36):468–474. doi:10.1051/lait:19243627.
   Google Scholar
• Reuter G. Comparative studies on the bifidus flora in the feces of infants and adults. with a contribution to classification and nomenclature of bifidus strains. Zentralbl Bakteriol Orig. 1963;191:486–507.
   PubMedGoogle Scholar
• Metchnikoff E. The prolongation of life. Optimistic Studies. G. P. Putnam’s Sons. 1908.
   Google Scholar
• Ozen M, Dinleyici EC. The history of probiotics: the untold story. Benef Microbes. 2015;6(2):159–165. doi:10.3920/BM2014.0103.
   PubMed Web of Science ®Google Scholar
• de Kruif P. The microbe hunters. New York: Blue Ribbon Books; 1926.
   Google Scholar
• Atlas RM. Probiotics–snake oil for the new millennium? Environ Microbiol. 1999;1(5):377–382. doi:10.1046/j.1462-2920.1999.00063.x.
   PubMed Web of Science ®Google Scholar
• Berg RD. Probiotics, prebiotics or “conbiotics”? Trends Microbiol. 1998;6(3):89–92. doi:10.1016/S0966-842X(98)01224-4.
   PubMed Web of Science ®Google Scholar
• McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, Henrissat B, Oozeer R, Cools-Portier S, Gobert G, et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med. 2011;3(106):106ra106. doi:10.1126/scitranslmed.3002701.
   PubMed Web of Science ®Google Scholar
• Rene Dubois The dreams of reason: science and utopias xii xii, Vol. 167New York: Columbia University Press, Ann Am Acad Pol Soc Sci. 1962. pp. 199
   Google Scholar
• Underwood MA, Salzman NH, Bennett SH, Barman M, Mills DA, Marcobal A, Tancredi DJ, Bevins CL, Sherman MP. A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids. J Pediatr Gastroenterol Nutr. 2009;48(2):216–225. doi:10.1097/MPG.0b013e31818de195.
   PubMed Web of Science ®Google Scholar
• Underwood MA, Kalanetra KM, Bokulich NA, Lewis ZT, Mirmiran M, Tancredi DJ, Mills DA. A comparison of two probiotic strains of bifidobacteria in premature infants. J Pediatr. 2013;163(6):1585–1591.e9. doi:10.1016/j.jpeds.2013.07.017.
   PubMed Web of Science ®Google Scholar
• Ellis CL, Bokulich NA, Kalanetra KM, Mirmiran M, Elumalai J, Haapanen L, Schegg T, Rutledge JC, Raff G, Mills DA, et al. Probiotic administration in congenital heart disease: a pilot study. J Perinatol. 2013;33(9):691–697. doi:10.1038/jp.2013.41.
   PubMed Web of Science ®Google Scholar
• Powell WT, Borghese RA, Kalanetra KM, Mirmiran M, Mills DA, Underwood MA. Probiotic administration in infants with gastroschisis: a pilot randomized placebo-controlled trial. J Pediatr Gastroenterol Nutr. 2016;62(6):852–857. doi:10.1097/MPG.0000000000001031.
   PubMed Web of Science ®Google Scholar
• Underwood MA, Davis JCC, Kalanetra KM, Gehlot S, Patole S, Tancredi DJ, Mills DA, Lebrilla CB, Simmer K. Digestion of human milk oligosaccharides by Bifidobacterium breve in the premature Infant. J Pediatr Gastroenterol Nutr. 2017;65(4):449–455. doi:10.1097/MPG.0000000000001590.
   PubMed Web of Science ®Google Scholar
• Xiao J-Z, Takahashi S, Odamaki T, Yaeshima T, Iwatsuki K. Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market. Biosci Biotechnol Biochem. 2010;74(2):336–342. doi:10.1271/bbb.90659.
   PubMed Web of Science ®Google Scholar
• Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C, Ledeboer NA, Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7):2234–2248. doi:10.1128/JCM.00150-17.
   PubMed Web of Science ®Google Scholar